Startech Early Ventures

Startech Early Ventures is a venture capital firm specializing in early-stage investments in technology-based companies. Founded in 1997 as a business incubator in Richardson, Texas, the firm focuses on sectors such as Information Technology, Communications, Smart Energy Systems, Technology-enabled Health Care, and Nanotech Processes and Materials. In 1998, Startech formed a seed-stage investment fund to complement its methodology for company creation and growth. The firm has established strong networks with executives, entrepreneurs, co-investors, and other partners, providing broad visibility into Texas deal flow. Additionally, Startech has taken a leading role in establishing relationships with Texas-based research institutes, including top-tier university systems, to translate technology commercialization initiatives into strong IP-based deal flow.

Startech Early Ventures has made 38 investments, with 15 portfolio exits. Notable investments include Reata Pharmaceuticals, which went public in 2016, and Nuventix, acquired by Aavid Thermalloy in 2014. The firm's portfolio also includes companies like MacroGenics, SensorLogic, and Pintail Technologies. Startech typically provides seed funding ranging from $100,000 to $900,000, allowing company founders to focus on product development. The firm has a history of successful exits, with companies like Reata Pharmaceuticals achieving significant milestones.

Overall, Startech Early Ventures plays a pivotal role in fostering technology-based startups in Texas, leveraging its extensive network and expertise to support the growth and success of its portfolio companies.